| 乳腺癌药物预防的新进展 |
| |
| 引用本文： | 莫文菊(综述),丁小文(审校). 乳腺癌药物预防的新进展[J]. 中国肿瘤临床, 2016, 43(23): 1058-1060. DOI: 10.3969/j.issn.1000-8179.2016.23.616 |
| |
| 作者姓名： | 莫文菊(综述) 丁小文(审校) |
| |
| 作者单位： | 作者单位:浙江省肿瘤医院乳腺外科(杭州市310022) |
| |
| 摘 要： | 随着我国乳腺癌的发病率逐年增高,对乳腺癌进行预防干预显得尤为重要。使用自然或人工合成的化学药物可以干预乳腺癌发生、发展的过程,达到预防乳腺癌的目的。本文通过回顾乳腺癌药物预防相关的临床试验,对该领域研究新进展进行综述。
|
| 关 键 词： | 乳腺癌? 预防? 激素受体调节剂 芳香化酶抑制剂 |
| 收稿时间： | 2016-05-26 |
Advances in medical prevention of breast cancer |
| |
| Affiliation: | Department of Breast Cancer, Zhejiang Cancer Hospital, Hangzhou 310022, China |
| |
| Abstract: | The development of optimal strategies for breast cancer prevention is necessary given the high incidence in China. Several prospective randomized clinical trials have investigated the effects of various pharmacologic agents on the incidence of invasive and noninvasive breast cancer. This review aimed to summarize the different approaches to reduce the incidence of breast cancer. |
| |
| Keywords: | breast cancer prevention selective estrogen receptor modulator aromatase inhibitor |
| 本文献已被 万方数据 等数据库收录！ |
| 点击此处可从《中国肿瘤临床》浏览原始摘要信息 |
|
点击此处可从《中国肿瘤临床》下载免费的PDF全文 |
